EM-T3Pharmacoepidemiology and Drug Safety2026-03-01第 35 卷第 3 期，e70343-e70343开放获取高影响力 · 前 10%
Early Identification of Cardiovascular Adverse Events Associated With Rofecoxib Using Real‐World Data From the UK : A Nested Case–Control and Case‐Crossover Study
